$52.96
0.100.19%
At close: -
$52.96
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
iRadimed Stock Guidance | NASDAQ:IRMD | Benzinga
iRadimed issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/13/2025 | IRMD | iRadimed | Q1 | 2025 | $0.39 | $0.43 | $0.41 | $19.20M | $19.40M | $19.13M | Get Alert |
| 02/13/2025 | IRMD | iRadimed | FY | 2025 | $1.71 | $1.81 | $1.75 | $78.00M | $82.00M | $80.66M | Get Alert |
| 01/10/2025 | IRMD | iRadimed | FY | 2024 | — | — | — | $73.10M | $73.30M | $72.82M | Get Alert |
| 01/10/2025 | IRMD | iRadimed | Q4 | 2024 | — | — | — | $19.20M | $19.40M | $18.94M | Get Alert |
| 10/31/2024 | IRMD | iRadimed | Q4 | 2024 | $0.42 | $0.45 | $0.40 | $18.80M | $19.20M | $19.26M | Get Alert |
| 10/31/2024 | IRMD | iRadimed | FY | 2024 | $1.64 | $1.67 | $1.56 | $72.70M | $73.10M | $72.62M | Get Alert |
| 08/01/2024 | IRMD | iRadimed | FY | 2024 | $1.52 | $1.62 | $1.53 | $72.00M | $74.00M | $72.29M | Get Alert |
| 08/01/2024 | IRMD | iRadimed | Q3 | 2024 | $0.38 | $0.41 | $0.37 | $18.00M | $18.20M | $17.70M | Get Alert |
| 05/02/2024 | IRMD | iRadimed | FY | 2024 | $1.52 | $1.62 | $1.52 | $72.00M | $74.00M | $72.31M | Get Alert |
| 05/02/2024 | IRMD | iRadimed | Q2 | 2024 | $0.36 | $0.39 | $0.37 | $17.60M | $17.80M | $17.88M | Get Alert |
| 02/08/2024 | IRMD | iRadimed | FY | 2024 | $1.52 | $1.62 | $1.67 | $72.00M | $74.00M | $72.60M | Get Alert |
| 02/08/2024 | IRMD | iRadimed | Q1 | 2024 | $0.33 | $0.35 | $0.41 | $17.00M | $17.30M | $17.61M | Get Alert |
| 01/09/2024 | IRMD | iRadimed | FY | 2023 | — | — | — | $65.60M | $65.60M | $65.07M | Get Alert |
| 01/09/2024 | IRMD | iRadimed | Q4 | 2023 | — | — | — | $17.50M | $17.50M | $17.13M | Get Alert |
| 11/03/2023 | IRMD | iRadimed | FY | 2023 | $1.48 | $1.51 | $1.26 | $65.00M | $65.50M | $64.77M | Get Alert |
| 11/03/2023 | IRMD | iRadimed | Q4 | 2023 | $0.38 | $0.41 | $0.34 | $16.90M | $17.40M | $16.15M | Get Alert |
| 08/03/2023 | IRMD | iRadimed | FY | 2023 | $1.37 | $1.40 | $1.30 | $64.50M | $65.50M | $63.09M | Get Alert |
| 08/03/2023 | IRMD | iRadimed | Q3 | 2023 | $0.36 | $0.38 | $0.33 | $16.10M | $16.30M | $15.60M | Get Alert |
| 05/04/2023 | IRMD | iRadimed | FY | 2023 | $1.26 | $1.35 | $1.31 | $62.00M | $63.50M | $62.51M | Get Alert |
| 05/04/2023 | IRMD | iRadimed | Q2 | 2023 | $0.30 | $0.32 | $0.30 | $15.60M | $15.80M | $15.10M | Get Alert |
| 02/02/2023 | IRMD | iRadimed | FY | 2023 | $1.23 | $1.34 | $1.30 | $61.00M | $63.00M | $62.84M | Get Alert |
| 02/02/2023 | IRMD | iRadimed | Q1 | 2023 | $0.26 | $0.28 | $0.29 | $14.60M | $14.90M | $14.80M | Get Alert |
| 01/18/2023 | IRMD | iRadimed | FY | 2023 | $1.23 | $1.34 | $1.26 | $61.00M | $63.00M | $61.02M | Get Alert |
| 01/18/2023 | IRMD | iRadimed | Q1 | 2023 | $0.26 | $0.28 | $0.31 | $14.60M | $14.90M | $14.90M | Get Alert |
| 01/18/2023 | IRMD | iRadimed | Q4 | 2022 | — | — | — | $14.90M | $14.90M | $14.63M | Get Alert |
| 11/03/2022 | IRMD | iRadimed | FY | 2022 | $1.03 | $1.08 | $1.02 | $52.50M | $53.20M | $52.92M | Get Alert |
| 11/03/2022 | IRMD | iRadimed | Q4 | 2022 | $0.25 | $0.30 | $0.29 | $14.10M | $14.80M | $14.71M | Get Alert |
| 10/10/2022 | IRMD | iRadimed | Q3 | 2022 | — | — | — | $13.40M | $13.40M | $13.19M | Get Alert |
| 07/29/2022 | IRMD | iRadimed | FY | 2022 | $0.96 | $1.03 | $1.01 | $52.50M | $53.20M | $52.63M | Get Alert |
| 07/29/2022 | IRMD | iRadimed | Q3 | 2022 | $0.22 | $0.25 | $0.25 | $13.10M | $13.30M | $13.07M | Get Alert |
| 04/29/2022 | IRMD | iRadimed | FY | 2022 | $0.96 | $1.03 | $0.98 | $52.50M | $53.20M | $51.98M | Get Alert |
| 04/29/2022 | IRMD | iRadimed | Q2 | 2022 | $0.23 | $0.25 | $0.23 | $12.50M | $12.70M | $12.42M | Get Alert |
| 02/04/2022 | IRMD | iRadimed | Q1 | 2022 | $0.20 | $0.21 | — | $12.10M | $12.30M | $11.07M | Get Alert |
| 02/04/2022 | IRMD | iRadimed | FY | 2022 | $0.91 | $1.01 | $0.83 | $51.40M | $52.20M | $45.62M | Get Alert |
| 10/29/2021 | IRMD | iRadimed | Q4 | 2021 | $0.20 | $0.21 | $0.17 | $11.50M | $11.70M | $10.75M | Get Alert |
| 10/29/2021 | IRMD | iRadimed | FY | 2021 | $0.70 | $0.71 | $0.62 | $41.40M | $41.60M | $40.16M | Get Alert |
| 07/30/2021 | IRMD | iRadimed | FY | 2021 | $0.60 | $0.62 | $0.53 | $40.00M | $40.40M | $37.52M | Get Alert |
| 07/30/2021 | IRMD | iRadimed | Q3 | 2021 | $0.16 | $0.17 | $0.13 | $10.30M | $10.50M | $9.37M | Get Alert |
FAQ
What is the most recent guidance for iRadimed (IRMD)?
The most recent guidance for iRadimed (IRMD) was reported on February 13, 2025 for Q1 2025. The company provided earnings per share guidance in the range of $0.39 to $0.43, compared to the estimated EPS of $0.41. Additionally, iRadimed forecasted revenue between $0.02B and $0.02B for the quarter.
Browse guidance and forecast on all stocks.